Sutter Health has named Dr. Shawn Kile as Chair of its Neuroscience Service Line, where he will help lead systemwide strategy and elevate neuroscience care across the integrated network. In this role, Dr. Kile will serve as physician dyad partner to Jean Minton, vice president of Sutter’s Neuroscience Service Line. His appointment begins May 12, 2025.
“Dr. Kile is a visionary leader in the care and science of memory disorders and has long been committed to integrating neuroscience care across Sutter Health. His appointment reflects Sutter’s continued investment in delivering high-quality, consistent and proactive care for all neurologic conditions,” said Minton. “Dr. Kile’s leadership will help shape the future of neuroscience at Sutter and build on our longstanding commitment to excellent care for the communities we serve.”
As Chair, Dr. Kile will guide strategic initiatives, clinical programming and capital planning, as well as drive research, philanthropic and quality initiatives. He, alongside Minton, will also oversee a team of section chiefs representing key neuroscience subspecialties – such as dementia, epilepsy and stroke – who together form Sutter’s Neuroscience Clinical Council. This group will work to strengthen care pathways, expand access to clinical trials and training and find new ways to collaborate and share clinical best practices across Sutter.
Dr. Shawn Kile
“I’m honored to assume this role, and I’m committed to continue building on Sutter’s strengths in neuroscience,” said Dr. Kile. “By advancing innovation and becoming truly integrated, I believe we can lead the nation in providing the best care for patients with neurologic conditions.”
About Dr. Kile
Dr. Kile is a neurologist subspecializing in cognitive neurology who has practiced since 2007 at Sutter Medical Center, Sacramento with Sutter Medical Group. He helped establish Sutter as a destination site for state-of-the-art neurologic care, including the treatment of Alzheimer’s disease, dementia and other memory disorders. At Sutter, he is known as a respected clinician, trusted leader, visionary researcher and dedicated faculty mentor.
Among his many accomplishments, Dr. Kile is renowned for establishing the Sutter Neuroscience Institute – Memory Clinic in Sacramento – a leading center in California for neurologic care and research for individuals with Alzheimer’s disease and other memory disorders. Additionally, Dr. Kile’s leadership and vision was instrumental to the launch of Sutter Medical Center Sacramento Comprehensive Stroke Program, Sutter Innovation Committee, Sutter Concussion Clinic, and the Sutter Transition for Autism and Neurodevelopmental Disorders (STAND) Clinic for adults with autism.
Lisamarie LaVallee, memory program manager for Sutter’s Health’s Neuroscience Service Line, left, and Dr. Shawn Kile, a board-certified neurologist with Sutter Medical Group and lead physician for the team that won Sutter’s inaugural Innovation Challenge in 2025.
Dr. Kile continually drives innovation to realize the future of medicine and problem-solve for patients who need solutions for complex, challenging illnesses. Most recently, his idea – a self-administered smartphone-based cognitive screen for Alzheimer’s disease and other forms of dementia – was selected as the top innovation among hundreds of submissions to Sutter’s first Innovation Challenge for its potential benefit to patients and clinicians.
A highly respected physician leader renowned across California and the United States, Dr. Kile regularly speaks at local and national conferences and patient advocacy groups on the resources, support, research and clinical care offered at Sutter that deliver a seamless, connected continuum of services for individuals with memory disorders.
Dr. Kile has published extensively in high-impact journals the findings of clinical trials testing investigational therapies for cognitive impairment, Alzheimer’s disease and dementia. His research efforts were pivotal to investigations focused on amyloid targeting immunotherapies and emphasized the importance of targeting the early stages of Alzheimer’s disease. Dr. Kile has served as Chair of the Sutter Health Research Assessment Council since 2024 and has encouraged collaborative research efforts across the system.
He consistently demonstrates the collegial spirit that brings together shared clinical best practices and a culture of curiosity that put patients first. His work partnering with colleague Dr. Armen Moughamian, medical director of Sutter’s Ray Dolby Brain Health Center in San Francisco was instrumental to the launch in 2023 of Sutter’s Advanced Therapeutics for Alzheimer’s Disease Review Board that positioned the health system as a leader in offering patients safe access to novel Alzheimer’s disease drugs.
Dr. Kile earned his medical degree from the University of Texas and completed dual residencies in neurology and psychiatry at the University of California, Davis. He is board-certified in neurology and is a member of the American Academy of Neurology, the American Medical Association and the San Francisco Neurological Society.
Read more about Sutter’s neurosciences programs:
